Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dermatological Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06643286
What this trial is testing

Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma

Who this might be right for
Melanoma (Skin)Melanoma, Stage II, Stage IMelanoma Stage+1 more
Erasmus Medical Center 180
Testing effectiveness (Phase 2)UnknownNCT03037970
What this trial is testing

Evaluation of ABSOLVE in Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot Ulcers
Lynch Biologics LLC 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05519670
What this trial is testing

A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr

Who this might be right for
Breast Cancer
Institut Paoli-Calmettes 72
Testing effectiveness (Phase 2)UnknownNCT02596373
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer

Who this might be right for
Advanced Recurrent or Metastatic Breast Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT00353717
What this trial is testing

Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma

Who this might be right for
Breast Neoplasms
Hadassah Medical Organization 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Post-approval studies (Phase 4)Study completedNCT01951417
What this trial is testing

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Who this might be right for
Acne
Galderma R&D 81
Testing effectiveness (Phase 2)Study completedNCT01257750
What this trial is testing

Treatment of Corneal Neovascularization With Topical Pazopanib

Who this might be right for
Corneal Neovascularization
Reza Dana, MD 20
Not applicableStudy completedNCT04583891
What this trial is testing

Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design

Who this might be right for
Depression, AnxietyEngagement, Patient
University of Virginia 313
Early research (Phase 1)Study completedNCT01176474
What this trial is testing

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 73
Testing effectiveness (Phase 2)UnknownNCT00471510
What this trial is testing

Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss

Who this might be right for
Androgenetic Alopecia
Neosil, Inc. 140
Testing effectiveness (Phase 2)Study completedNCT00938223
What this trial is testing

Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 51
Early research (Phase 1)Ended earlyNCT00972023
What this trial is testing

DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 1
Testing effectiveness (Phase 2)Study completedNCT01080079
What this trial is testing

Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis

Who this might be right for
Onychomycosis
Nitric BioTherapeutics, Inc 168
Testing effectiveness (Phase 2)Looking for participantsNCT05423262
What this trial is testing

TRK-950 in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorMelanoma
Toray Industries, Inc 49
Large-scale testing (Phase 3)Study completedNCT00096603
What this trial is testing

Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g

Who this might be right for
Psoriasis
Genentech, Inc. 450
Testing effectiveness (Phase 2)Study completedNCT05217303
What this trial is testing

HL-085 in NRAS-mutated Advanced Melanoma

Who this might be right for
Melanoma
Shanghai Kechow Pharma, Inc. 100
Not applicableUnknownNCT04171427
What this trial is testing

Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo

Who this might be right for
Vitiligo
Laboratoire Dermatologique ACM 12
Not applicableStudy completedNCT04510961
What this trial is testing

Paraffin Bath Therapy for Chronic Hand Eczema

Who this might be right for
Eczema
Cairo University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06176261
What this trial is testing

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Who this might be right for
Breast CancerBreast Cancer FemaleMetastatic Triple-Negative Breast Carcinoma+4 more
Nancy Lin, MD 58
Next Page